1-8 of 8
Mette K. Andersen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Characterization Of De Novo and Therapy-Related MDS/AML With Der(1;7)(q10;p10)

Westman K Maj, MSc, Mette K. Andersen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2585.
https://doi.org/10.1182/blood.V122.21.2585.2585
Published: 2013
Journal Articles

High Early Death Rate with Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia Confirmed in Unselected Patients: Results of a Population-Based Registry Study

Jan M. Norgaard, MD, PhD, Lene Sofie Granfeldt Ostgard, MD, Eigil Kjeldsen, MD, Mette S. Holm, MD, PhD, Lars Kjeldsen, MD, PhD, Maria Kallenbach, MD, Marianne T. Severinsen, MD, PhD, Preben Johansen, MD, Lone S. Friis, MD, PhD, Duruta Weber, MD, PhD, Gitte Kerndrup, Birgitte Preiss, MD, Morten K. Jensen, MD, Inge H. Dufva, MD, Susanne Timshel, MD, Mette K. Andersen, MD, PhD, Ove J. Nielsen, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3542.
https://doi.org/10.1182/blood.V120.21.3542.3542
Published: 2012
Journal Articles

Different Cytogenetic Patterns in Specified Categories of Secondary AML: Results of a Population-Based Registry Study,

Jan M. Norgaard, MD, PhD, Lene S.G. Oestgaard, MD, Mette K. Andersen, MD, PhD, Maria Kallenbach, MD, Preben Johansen, MD, Knud Bendix, MD, PhD, Gitte Kerndrup, MD, PhD, Birgitte Preiss, MD, Inge Dufva, MD, Susanne Timshel, MD, Joergen Kristensen, MD, PhD, Peter de Nully Brown
Journal: Blood
Blood (2011) 118 (21): 3586.
https://doi.org/10.1182/blood.V118.21.3586.3586
Published: 2011
Journal Articles

IDH1 and IDH2 Mutations in Therapy-Related Acute Myeloid Leukemia Are Associated with a Normal Karyotype or Der(1;7)(q10;p10) Combined with RUNX1 Mutations,

Maj K. Westman, Morten T. Andersen, Jens Pedersen-Bjergaard, MD, PhD, Mette K. Andersen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3514.
https://doi.org/10.1182/blood.V118.21.3514.3514
Published: 2011
Journal Articles

Epigenetic Silencing of a Novel Candidate Tumor Suppressor “miR” Predicts Poor Prognosis In High-Risk MDS and AML.

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Christoffer Hother, MD, Mette K. Andersen, MD, PhD, Lars Kjeldsen, MD, PhD, Peter Jones, Professor, Gangning Liang, PhD, Kirsten Gr∅nbæk, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3629.
https://doi.org/10.1182/blood.V116.21.3629.3629
Published: 2010
Journal Articles

Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Genome-Wide Screening Reveals the Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations.

Josef Davidsson, PhD, Kajsa Paulsson, PhD, David Lindgren, PhD, Henrik Lilljebjörn, MS, Tracy Chaplin, MS, Erik Forestier, MD, PhD, Mette K Andersen, MD, PhD, Ann Nordgren, MD, PhD, Richard Rosenquist, MD, PhD, Thoas Fioretos, MD, PhD, Bryan D Young, PhD, Bertil Johansson, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2591.
https://doi.org/10.1182/blood.V114.22.2591.2591
Published: 2009
Journal Articles

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

Par Josefsson, MD, Jesper Jurlander, MD, PhD, Christian H. Geisler, MDD.MS, Lone B. Pedersen, Lone Bach, Mette K. Andersen, MD, Henrik Leffers, MS, Anne Mette Buhl, PhD
Journal: Blood
Blood (2005) 106 (11): 709.
https://doi.org/10.1182/blood.V106.11.709.709
Published: 2005
Journal Articles

Genetic Pathways in t-MDS and t-AML, a Revised Model.

Jens Pedersen-Bjergaard, MD, Ph.D, Debes H. Christiansen, MS, Mette K. Andersen, MD
Journal: Blood
Blood (2004) 104 (11): 2993.
https://doi.org/10.1182/blood.V104.11.2993.2993
Published: 2004